In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Gabapentin, Fanatrex, Gabarone, Neurontin Drug Master File in Korea (Gabapentin, Fanatrex, Gabarone, Neurontin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Gabapentin, Fanatrex, Gabarone, Neurontin. The MFDS reviews the Gabapentin, Fanatrex, Gabarone, Neurontin KDMF as part of the drug registration process and uses the information provided in the Gabapentin, Fanatrex, Gabarone, Neurontin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Gabapentin, Fanatrex, Gabarone, Neurontin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Gabapentin, Fanatrex, Gabarone, Neurontin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Gabapentin, Fanatrex, Gabarone, Neurontin suppliers with KDMF on PharmaCompass.